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INTRODUCTION
Through the development of assisted reproductive
technology (ART), in vitro fertilization and embryo
transfer (IVF-ET) and intracytoplasmic sperm injec-
tion (ICSI) have assumed central roles in the treat-
ment of infertility. However, numerous patients do
not conceive even after several cycles of ART. Pos-
sible causes of failure after repeated attempts with
ART include increasing tendency of getting married
at a late age, poor response to ovulation induction,
problems with embryo implantation, and male fac-
tors. Various trials have been accomplished for poor
responder in each institution. Jinno et al proposed
that patients with poor IVF outcomes using the long
protocol may have low responsiveness of granulose
cell to PRL (1). They proposed the bromocriptine-
rebound (BR) method as a possible treatment op-
tions (2). The aim of this study was to examine
whether the BR method improved pregnancy out-
comes in women with previous unsuccessful ART
attempts.
PATIENTS AND METHODS
Patients and study design :
In this study we retrospectively analyzed data
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from a total of 121 women with normal serum
prolactin (PRL) levels and a history of repeated un-
successful IVF or ICSI procedures at the University
of Tokushima from March 1998 to October 2000.
IVF/ICSI outcomes and hormonal data were com-
pared between 99 woman with the long protocol and
22 women in the BR method. Patient background
was shown in Table 1.
Ovarian stimulation regimens :
In the long protocol, we initiated administration
of buserelin acetate (600 micro g/day ; Suprecur,
Hoechst, Tokyo, Japan) on the 7th day of high phase
of basal body temperature before treatment. After
menstruation started, ovarian stimulation was started
with 150 IU of follicle-stimulating hormone (FSH ;
Fertinom P, Serono, Tokyo) for 4 days and then
225 U of human menopausal gonadotropin (HMG ;
Humegon, Organon, Osaka, Japan) for 5 days, fol-
lowed by administration of human chorionic gona-
dotropin (hCG) 5,000 IU. Oocytes were collected 36
h after hCG administration. In the BR method, bro-
mocriptine (2.5 mg/day, Teluron, Bayer pharma,
Osaka, Japan) was administered orally daily from
day 5 of the preceding cycle until 7 days before
ovarian stimulation (Figure 1).
IVF-ET procedure :
Motile spermatozoa were collected by the swim-
up technique. Oocytes were cultured in human tu-
bal fluid medium (Irvine Science, Santa Ana, CA,
USA), to which 10% of the patient’s serum was
added for 2-4 h, and inseminated at a concentration
of 50,000/ml motile spermatozoa. Oocytes were
considered to be fertilized when 2 pronuclei were
observed 14-16 h after insemination. Embryos were
transferred 40-48 h after insemination. At 38-40 h
after insemination, we evaluated embryos according
to the criteria shown in Table 2. Embryo transfer
Table 1. Patient background
Long
protocol
(n=99)
Bromocriptine
rebound method
(n=22)
Average age(y) 35.14.3 35.43.7
LH(mIU/ml) 4.72.4 4.82.7
FSH(mIU/ml) 7.92.5 7.93.0
PRL(ng/ml) 7.58.3 5.93.3
Values are presented as the meanS.D.
Figure 1 Ovarian stimulation regimens
OPU : oocyte pick-up
BBT : basal body temperature
Table 2 Embryo evaluation method at the University of
Tokushima
Point 0 2 3 5
The number of the
blastomeres 1 --- 2
3 4≦
Fragmentation (%) 50 25 50 25 0
Demerit mark item
-2 points
Zona pellucida transformation, Cytoplasm
black Vacuole denaturation, Blastomere big
things and small things inequality
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of 1-3 embryos was performed according to the rec-
ommendation from the Japan Society of Obstetrics
and Gynecology. We administered hCG 1,500 U/day
3 times every 3rd day from the embryo transfer day.
Statistical analysis :
Data were analyzed using Student’s t -test and the
chi-square test. P0.05 was considered statistically
significant. Results are presented as meanS.D.
unless otherwise stated.
RESULTS
The peak value of estradiol was 2,125 pg/ml with
the BR method and 1,790 pg/ml with the long proto-
col, and the differences were not significant (Figure
2). The results of the long protocol and the BR
method are summarized in Table 3. The number of
fertilized oocytes, cleaved embryos and transplant
embryos were significantly higher with the BR
method than with the long protocol (4.03.5 vs.
5.43.7, 3.83.3 vs. 5.03.6, 2.31.1, 2.71.0, re-
spectively ; P0.05) even though no significant dif-
ferences were observed in the number of retrieved
oocytes between the long protocol and BR method.
The clinical pregnancy rate was significantly higher
with the BR method than with the long protocol.
The mean embryo score with the BR method was
significantly higher than that with the long protocol
(6.01.4, 5.22.5, respectively ; P0.05)(deta was
not shown). The ratio of the good embryos (6
points) was higher with the BR method than with
the long protocol (P0.05).
DISCUSSION
In our study, morphologically better embryos can
be transplanted using the BR method in woman with
previous failed ART attempts. PRL is known to play
a significant role in regulating ovarian functions, in-
cluding folliculogenesis, steroid genesis, ovulation,
and corpus lutenum function (3, 4). PRL levels are
generally high in patients with ovulation and ster-
oidogenesis disorders. It is reported that in the hy-
poprolactinemia, the rate of cleavage embryo and
pregnancy rate was low. In addition, serum PRL lev-
els after hCG administration are higher in pregnant
women than in non-pregnant women after IVF (5).
In a study of rabbit oocytes, addition of PRL to the
culture fluid was found to promote oocyte maturity
(6).
The serum PRL levels with the BR method con-
tinuously increased 4 days after the end of bro-
mocriptine administration to the day hCG was ad-
ministered (2). A follicular PRL receptor has been
reported in connection with human IVF (3, 7, 8),
and a high concentration of PRL in the follicular
fluid was associated with maturation of the oocyte-
cumulus complex, resulting in successful fertiliza-
tion and pregnancy (9). Jinno et al . proposed that
the granulosa cells in patients with poor IVF out-
comes after the long protocol may show low respon-
siveness to PRL, possibly in the postreceptor path-
way, thereby causing compensatory increases in the
levels of serum PRL. They suggested that in such
patients, the BR method probably improves oocyte
maturation by restoring postreceptor responsiveness
of the granulosa cells to PRL during the hypoprolac-
tinemic period and increasing the serum PRL con-
centration through a rebound phenomenon after
Table. 3 In vitro fertilization outcomes for long protocol and
Bromocriptin-rebound method
Long
protocol
(n=99)
Bromocriptin
rebound method
(n=22)
Retrieved oocytes 7.54.9 8.25.0
Fertilized oocytes 4.03.5 5.43.7a
Cleaves embryos 3.83.3 5.03.6a
Transplant embryos 2.31.1 2.71.0a
Clinical pregnancies 10.1%(10/99) 27.2%(6/22)b
Total embryo quality* 24.4%(180/738) 32.8%(59/180)b
Values are presented as meanS.D.
*Good embryo :6 points in Tokushima University’s criteria
aP0.05 compared with the long protocol (t - test, unpaired)
bP0.05 compared with the long protocol (χ2 - test)
Figure 2 Serum estradiol concentration
Estradiol levels are higher with the BR method compared to
those with the long protocol, but the differences are not signifi-
cant. Data were analyzed by unpaired t test.
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discontinuation of bromocriptine (2).
In our study, serum PRL levels in BR method and
long protocol showed no significant difference. How-
ever, the embryo quality was significantly improved
in cases with BR method. Application of the BR
method in women with previous unsuccessful ART
attempts appears to increase serum PRL values dur-
ing ovarian stimulation and promote oocyte matu-
ration through the presence of PRL receptors in the
granulosa cells even in normal PRL patients. An in-
crease in the number of normal embryos can be ex-
pected to result in improved pregnancy outcomes
(10). These factors increase the fertility rate and im-
prove embryo quality, but the underlying mecha-
nism is still unclear.
In conclusion, the BR method could provide the
better quality in retrieved oocytes and improve em-
bryo quality and number of developing embryos,
then improve the transplantation rate in women with
previous unsuccessful ART attempts
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